This contract expires in 164 days (Mar 31, 2027).

RHO FEDERAL SYSTEMS DIVISION INC - INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

PIID: 75A50122F33004

Signed Date: Sep 27, 2022Effective Date: Sep 27, 2022End Date: Closes in 164 days

Award $

$3.0M

Vendor

RHO FEDERAL SYSTEMS DIVISION INC

NAICS

541715

Signed Date

Sep 27, 2022

Key Details

Dollars Obligated

$3.0M

Base & All Options

$3.0M

Awarding Agency

Awarding Sub-Agency

Office of Assistant Secretary for Preparedness and Response

NAICS Code

Parent IDIQ (PIID)

75A50120D00015

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

DURHAM, NC

INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

On Sep 27, 2022, Department of Health and Human Services obligated $2,983,502 to RHO FEDERAL SYSTEMS DIVISION INC for integrated safety summary report of clinical studies assessing safety of influenza vaccines administered with as03 or mf59 adjuvant.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Mar 31, 2027 — approximately 5 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.